Regeneron (REGN) Stock Research

Regeneron

· REGN

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

77.269 B

+1.03%

Monday

Kodiak Sciences price target raised to $145 from $85 at LifeSci Capital

Sep 28, 1:01 PM

Kodiak data raises competitive bar for Regeneron, says Citi

Sep 28, 11:47 AM

Over a week ago

Regeneron price target raised by $120 at HSBC, here's why

REGN

Sep 10, 6:25 AM

Veeva price target raised to $310 from $270 at Needham

Aug 27, 7:59 AM

Private Markets: $1B for Base Power, $545M for Whatnot

+32

Aug 20, 10:42 AM

Regeneron's Pasatru granted FDA approval for FOP

REGN

Aug 20, 9:17 AM

Regeneron price target raised by $183 at Leerink

REGN

Aug 17, 6:06 AM

Private Markets: Databricks secures $5B as Kalshi targets $40B valuation

+26

Aug 13, 11:05 AM

Regeneron announces Health Canada approval of new indication for Libtayo

REGN

Aug 6, 11:33 AM

Regeneron price target raised by $30 at Guggenheim, here's why

REGN

Aug 3, 9:29 AM

Regeneron price target raised by $40 at Citi, here's why

REGN

Aug 3, 6:36 AM

Regeneron price target raised by $41 at RBC Capital, here's why

Jul 31, 10:01 AM

Regeneron price target raised by $28 at Morgan Stanley, here's why

REGN

Jul 31, 9:07 AM

Regeneron price target raised by $35 at BofA, here's why

REGN

Jul 31, 8:57 AM

Regeneron price target raised by $45 at Cantor Fitzgerald, here's why

REGN

Jul 31, 8:25 AM

Regeneron price target raised by $19 at Baird, here's why

REGN

Jul 31, 7:22 AM

Regeneron price target raised by $50 at Wells Fargo, here's why

REGN

Jul 31, 6:17 AM

Regeneron cuts FY26 CapEx view to $1.03B-$1.1B from $1.1B-$1.2B

REGN

Jul 30, 8:17 AM

Regeneron reports Q2 adjusted EPS $14.29, consensus $10.20

REGN

Jul 30, 6:31 AM

Regeneron price target raised by $5 at Guggenheim, here's why

REGN

Jul 21, 8:01 AM

Biohaven enters into clinical supply agreement with Regeneron

Jul 20, 7:34 AM

Regeneron's dupilumab granted orphan drug designation

REGN

Jul 14, 5:03 PM

Regeneron price target lowered by $4 at BofA, here's why

REGN

Jul 13, 7:15 AM

Regeneron price target lowered by $1 at Piper Sandler, here's why

REGN

Jul 9, 7:13 AM

Regeneron price target lowered by $58 at Morgan Stanley, here's why

REGN

Jul 8, 7:39 AM

Charts

Monday

Kodiak Sciences price target raised to $145 from $85 at LifeSci Capital

Sep 28, 1:01 PM

Kodiak data raises competitive bar for Regeneron, says Citi

Sep 28, 11:47 AM

Over a week ago

Regeneron price target raised by $120 at HSBC, here's why

REGN

Sep 10, 6:25 AM

Veeva price target raised to $310 from $270 at Needham

Aug 27, 7:59 AM

Private Markets: $1B for Base Power, $545M for Whatnot

+32

Aug 20, 10:42 AM

Regeneron's Pasatru granted FDA approval for FOP

REGN

Aug 20, 9:17 AM

Regeneron price target raised by $183 at Leerink

REGN

Aug 17, 6:06 AM

Private Markets: Databricks secures $5B as Kalshi targets $40B valuation

+26

Aug 13, 11:05 AM

Regeneron announces Health Canada approval of new indication for Libtayo

REGN

Aug 6, 11:33 AM

Regeneron price target raised by $30 at Guggenheim, here's why

REGN

Aug 3, 9:29 AM

Regeneron price target raised by $40 at Citi, here's why

REGN

Aug 3, 6:36 AM

Regeneron price target raised by $41 at RBC Capital, here's why

Jul 31, 10:01 AM

Regeneron price target raised by $28 at Morgan Stanley, here's why

REGN

Jul 31, 9:07 AM

Regeneron price target raised by $35 at BofA, here's why

REGN

Jul 31, 8:57 AM

Regeneron price target raised by $45 at Cantor Fitzgerald, here's why

REGN

Jul 31, 8:25 AM

Regeneron price target raised by $19 at Baird, here's why

REGN

Jul 31, 7:22 AM

Regeneron price target raised by $50 at Wells Fargo, here's why

REGN

Jul 31, 6:17 AM

Regeneron cuts FY26 CapEx view to $1.03B-$1.1B from $1.1B-$1.2B

REGN

Jul 30, 8:17 AM

Regeneron reports Q2 adjusted EPS $14.29, consensus $10.20

REGN

Jul 30, 6:31 AM

Regeneron price target raised by $5 at Guggenheim, here's why

REGN

Jul 21, 8:01 AM

Biohaven enters into clinical supply agreement with Regeneron

Jul 20, 7:34 AM

Regeneron's dupilumab granted orphan drug designation

REGN

Jul 14, 5:03 PM

Regeneron price target lowered by $4 at BofA, here's why

REGN

Jul 13, 7:15 AM

Regeneron price target lowered by $1 at Piper Sandler, here's why

REGN

Jul 9, 7:13 AM

Regeneron price target lowered by $58 at Morgan Stanley, here's why

REGN

Jul 8, 7:39 AM

Company News

Charts

Regeneron

· REGN

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

Company News

Charts

Regeneron

· REGN

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics